Latest Regulatory Approvals News

Zenith Minerals has successfully raised A$3.5 million through a fully underwritten rights issue, positioning the company to fast-track exploration and resource growth at its key gold projects in Western Australia and Queensland.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Mithril Silver and Gold Limited has announced a C$10 million brokered private placement to fund expanded exploration at its Copalquin district project in Mexico. The raise includes an option for agents to increase the placement by 15%, underscoring strong investor interest.

Island Pharmaceuticals has accelerated its acquisition of the Galidesivir antiviral program from BioCryst Pharmaceuticals, adding a clinically advanced asset with significant US government backing and a promising regulatory pathway.

Siren Gold reveals promising expansion and development prospects at its Sams Creek Project in New Zealand, with recent drilling uncovering new mineralised zones and a mining permit decision expected by year-end.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

Capricorn Metals has agreed to acquire the Claw Gold Project adjacent to its Mt Gibson operation, aiming to unlock new gold resources in Western Australia’s prolific Murchison region.

Lakes Blue Energy has secured all regulatory approvals to begin drilling the Wombat-5 well in Gippsland, aiming to tap a significant gas resource with potential to ease Victoria’s looming supply crunch.

Vigorous Resources has launched an unconditional off-market takeover bid for all shares in Rey Resources at a 160% premium, backed by unanimous board support and funding from a major shareholder.

Manuka Resources has launched a fully underwritten A$8 million entitlement offer to fund the restart of its Wonawinta processing plant and advance its 10-year Cobar Basin Production Plan, targeting silver and gold output by early 2026.

North Stawell Minerals has extended the closing date of its non-renounceable entitlement offer by two weeks, giving shareholders more time to participate in the $2.1 million capital raise.

L1 Capital and Platinum Asset Management have formalised their merger with a binding agreement, promising continuity for L1 Long Short Fund's management and strategy.